- Filed
- Sep 22, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Jul 31, 2025 | 21.86M sh |
| Shares Diluted | Q1 2026 · Jul 31, 2024 | 19.69M sh |
| Operating Cash Flow | Q1 2026 · Jul 31, 2025 | $1.09M |
| Operating Cash Flow | Q1 2026 · Jul 31, 2024 | $3.59M |
| Long Term Debt | Q1 2026 · Jul 31, 2025 | $2.6M |
| Cash And Equivalents | Q1 2026 · Jul 31, 2025 | $1.07M |
| Cash And Equivalents | Q1 2026 · Apr 30, 2025 | $775.36K |
| Stockholders Equity | Q1 2026 · Jul 31, 2025 | $10.13M |
| Stockholders Equity | Q1 2026 · Apr 30, 2025 | $11.67M |
| Current Liabilities | Q1 2026 · Jul 31, 2025 | $23.12M |
| Current Liabilities | Q1 2026 · Apr 30, 2025 | $21.91M |
| Total Liabilities | Q1 2026 · Jul 31, 2025 | $63.36M |
| Total Liabilities | Q1 2026 · Apr 30, 2025 | $65.72M |
| Current Assets | Q1 2026 · Jul 31, 2025 | $13.34M |
| Current Assets | Q1 2026 · Apr 30, 2025 | $12.48M |
| Total Assets | Q1 2026 · Jul 31, 2025 | $73.34M |
| Total Assets | Q1 2026 · Apr 30, 2025 | $77.36M |
| Eps Diluted | Q1 2026 · Jul 31, 2025 | −$0.08 |
| Eps Diluted | Q1 2026 · Jul 31, 2024 | $0.04 |
| Eps Basic | Q1 2026 · Jul 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Jul 31, 2024 | $0.04 |
| Sga Expense | Q1 2026 · Jul 31, 2025 | $1.61M |
| Sga Expense restated | Q1 2026 · Jul 31, 2024 | $1.6M |
| Net Income | Q1 2026 · Jul 31, 2025 | −$1.54M |
| Net Income | Q1 2026 · Jul 31, 2024 | $700.91K |
| Operating Income | Q1 2026 · Jul 31, 2025 | $184.22K |
| Operating Income restated | Q1 2026 · Jul 31, 2024 | $2.07M |
| Gross Profit | Q1 2026 · Jul 31, 2025 | $6.56M |
| Gross Profit restated | Q1 2026 · Jul 31, 2024 | $8.14M |
| Revenue | Q1 2026 · Jul 31, 2025 | $27.17M |
| Revenue restated | Q1 2026 · Jul 31, 2024 | $28.18M |